Your browser doesn't support javascript.
loading
Estimating deaths averted and cost per life saved by scaling up mRNA COVID-19 vaccination in low-income and lower-middle-income countries in the COVID-19 Omicron variant era: a modelling study.
Savinkina, Alexandra; Bilinski, Alyssa; Fitzpatrick, Meagan; Paltiel, A David; Rizvi, Zain; Salomon, Joshua; Thornhill, Thomas; Gonsalves, Gregg.
  • Savinkina A; Department of Epidemiology of Microbial Diseases, Yale University School of Public Health, New Haven, Connecticut, USA alexandra.savinkina@yale.edu.
  • Bilinski A; Public Health Modeling Unit, Yale University School of Public Health, New Haven, Connecticut, USA.
  • Fitzpatrick M; Departments of Health Services, Policy, and Practice and Biostatistics, Brown University, Providence, Rhode Island, USA.
  • Paltiel AD; Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, Maryland, USA.
  • Rizvi Z; Public Health Modeling Unit, Yale University School of Public Health, New Haven, Connecticut, USA.
  • Salomon J; Department of Health Policy and Management, Yale University School of Public Health, New Haven, Connecticut, USA.
  • Thornhill T; Public Citizen, Washington, District of Columbia, USA.
  • Gonsalves G; Center for Health Policy/Primary Care and Outcomes Research, Stanford University School of Medicine, Stanford, California, USA.
BMJ Open ; 12(9): e061752, 2022 09 13.
Article en En | MEDLINE | ID: mdl-36100306

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Países en Desarrollo / COVID-19 Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Países en Desarrollo / COVID-19 Tipo de estudio: Health_economic_evaluation / Prognostic_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article